$14.24
-0.13-0.87%
Last update: Nov 13, 12:17 PM
Crescent Biopharma Inc
CBIONASDAQ
Crescent Biopharma (CBIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $-0.90 | $-0.60 | -50.0 % |
| Q2 | Jul 30, 2026 | $-0.74 | $-0.67 | -10.4 % |
| Q1 | Apr 29, 2026 | $-0.70 | $-0.80 | 12.5 % |
| Q4 | Feb 26, 2026 | $-4.01 | $-2.58 | -55.4 % |
Quarterly Revenue (Billions)
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $3.12M | $357.14K | 772.8 % |
| Q2 | Jul 30, 2026 | $0 | $357.14K | -100.0 % |
| Q1 | Apr 29, 2026 | $1.04M | $357.14K | 190.9 % |
| Q4 | Feb 26, 2026 | $10.84M | $12.50M | -13.3 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.60 | $-0.67 | $-0.80 | $-2.58 |
| Actual | $-0.90 | $-0.74 | $-0.70 | $-4.01 |
| Surprise | -50.0% | -10.4% | +12.5% | -55.4% |
| Revenue | ||||
| Estimate | $357140 | $357140 | $357140 | $12.5M |
| Actual | $3.1M | $0 | $1.0M | $10.8M |
| Surprise | +772.8% | -100.0% | +190.9% | -13.3% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.64 | $-0.86 | $-0.91 |
| Revenue | |||
| Consensus | $357140 | — | — |
